AGILIS NXT INTRODUCER, UNKNOWN
Report
- Report Number
- 3008452825-2025-00007
- Event Type
- Injury
- Date Received
- January 5, 2025
- Report Date
- February 26, 2025
- Manufacturer
- ST. JUDE MEDICAL
- Product Code
- DYB
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NL
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
MODEL/LOT NUMBER INFORMATION WAS NOT ABLE TO BE OBTAINED FOR THIS DEVICE. THEREFORE, FULL UDI INFORMATION(D4) AND 510K(G3) ARE NOT AVAILABLE.
ADDITIONAL INFORMATION: G3, H2, H3, H6, H11. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. REVIEW OF THE DEVICE HISTORY RECORD WAS NOT POSSIBLE AS THE LOT NUMBER IS UNKNOWN. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.
THE FOLLOWING WAS PUBLISHED IN THE JOURNAL OF ARRHYTHMIA, IN AN ARTICLE TITLED "PREDICTORS OF LONG-TERM SUCCESS AFTER HIGH-DENSITY MAPPING-GUIDED SUBSTRATE ABLATION PROCEDURES FOR VENTRICULAR TACHYCARDIA IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY"; 2024;40:1442¿1451.BALT, J.C., DOI:10.1002/JOA3.13175 OBSERVATIONAL COHORT STUDY INCLUDES PATIENTS WITH ISCHEMIC HEART DISEASE WHO UNDERWENT HD MAPPING- GUIDED SUBSTRATE ABLATION OF VENTRICULAR TACHYCARDIA. BASELINE AND PROCEDURAL CHARACTERISTICS WERE ASSOCIATED WITH OUTCOMES AFTER VENTRICULAR TACHYCARDIA ABLATION. THE WAS ONE OCCURRENCE OF A VASCULAR COMPLICATION AND 2 CARDIAC TAMPONADES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1136551 | AGILIS NXT INTRODUCER, UNKNOWN | INTRODUCER, CATHETER | DYB | ST. JUDE MEDICAL |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | TACTICATH CONTACT FORCE ABLATION CATHETER, SE |